Senate Drug Pricing Bill: Even Worse Than The House Version

US Senate’s updated version of drug pricing legislation is even worse for industry when it comes to the proposed price ‘negotiation’ authority, a Congressional Budget Office analysis indicates. The big numbers facing the industry just keep getting bigger.

bad and worse
• Source: Shutterstock

The US Congressional Budget Office’s bottom line on the Senate version of drug pricing legislation might lead you to believe that it is a bit better for the drug industry than the version that already passed the House in 2021.

The Senate language is part of a last-ditch effort to salvage some portion of the “Build Back Better” bill that...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet